CD93 a potential player in cytotrophoblast and endothelial cell migration

被引:18
|
作者
Fantone, Sonia [1 ]
Tossetta, Giovanni [1 ,2 ,3 ]
Di Simone, Nicoletta [4 ]
Tersigni, Chiara [5 ,6 ]
Scambia, Giovanni [5 ,6 ]
Marcheggiani, Fabio [7 ]
Giannubilo, Stefano R. [2 ]
Marzioni, Daniela [1 ]
机构
[1] Univ Politecn Marche, Dept Expt & Clin Med, I-60126 Ancona, Italy
[2] Univ Politecn Marche, Azienda Osped Univ, Salesi Hosp, Dept Clin Sci, Ancona, Italy
[3] Humanitas Univ, Dept Biomed Sci, Via Rita Levi Montalcini 4, I-20072 Milan, Italy
[4] Humanitas Res Hosp, IRCCS, Via Manzoni 56, Milan, Italy
[5] Fdn Policlin Univ A Gemelli IRCCS, OUC Ostetricia Patol Ostetr, Dipartimento Sci Salute Donna, Bambino Sanita Pubbl, I-00168 Rome, Italy
[6] Univ Cattolica Sacro Cuore, Ist Clin Ostetr Ginecol, I-00168 Rome, Italy
[7] Univ Politecn Marche, Dept Life & Environm Sci, I-60131 Ancona, Italy
关键词
Preeclampsia (PE); CD93; Complement component C1q receptor; Placenta; Angiogenesis; IN-VITRO; TROPHOBLAST; ANGIOGENESIS; EXPRESSION; INVASION; SURFACE; ADHESION; RECEPTOR; C1QR(P);
D O I
10.1007/s00441-021-03543-3
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
CD93, also known as complement component C1q receptor, is expressed on the surface of different cellular types such as monocytes, neutrophils, platelets, microglia, and endothelial cells, and it plays a pivotal role in cell proliferation, cell migration, and formation of capillary-like structures. These processes are strictly regulated, and many fetal and maternal players are involved during placental development. At present, there are no studies in literature regarding CD93 in placental development, so we investigated CD93 expression in first and third trimester and PE placentas by immunohistochemistry and western blotting analysis. In addition, we performed in vitro experiments under oxidative stress conditions to demonstrate how oxidative stress acts on CD93 protein expression. Our data showed that CD93 was expressed in villous cytotrophoblast cells, in some fetal vessels of first and third trimester and PE placentas and in the extravillous cytotrophoblast of cell columns in the first trimester placentas. Moreover, we detected a significant decrease of CD93 expression in third trimester and PE placentas compared to first trimester placentas, while no differences were detected between third and PE placentas. No differences of CD93 expression were detected in oxidative stress conditions. We suggest that CD93 can guide extravillous cytotrophoblast migration through beta 1-integrin in uterine spiral arteries during placentation in the first trimester of pregnancy and that the decrease of CD93 expression in third trimester and PE placentas could be linked to the poor extravillous cytotrophoblast cells migration. So, it might be interesting to understand the role of CD93 in the first phases of PE onset.
引用
收藏
页码:123 / 130
页数:8
相关论文
共 50 条
  • [21] Structural insight into CD93 recognition by IGFBP7
    Xu, Yueming
    Sun, Yi
    Zhu, Yuwen
    Song, Gaojie
    STRUCTURE, 2024, 32 (03) : 282 - 291.e4
  • [22] The Epidermal Growth Factor-like Domain of CD93 Is a Potent Angiogenic Factor
    Kao, Yuan-Chung
    Jiang, Shinn-Jong
    Pan, Wen-An
    Wang, Kuan-Chieh
    Chen, Po-Ku
    Wei, Hsi-Ju
    Chen, Wei-Sheng
    Chang, Bi-Ing
    Shi, Guey-Yueh
    Wu, Hua-Lin
    PLOS ONE, 2012, 7 (12):
  • [23] Blockade of the CD93 pathway normalizes tumor vasculature to facilitate drug delivery and immunotherapy
    Sun, Yi
    Chen, Wei
    Torphy, Robert J.
    Yao, Sheng
    Zhu, Gefeng
    Lin, Ronggui
    Lugano, Roberta
    Miller, Emily N.
    Fujiwara, Yuki
    Bian, Li
    Zheng, Linghua
    Anand, Sudarshan
    Gao, Fan
    Zhang, Weizhou
    Ferrara, Sarah E.
    Goodspeed, Andrew E.
    Dimberg, Anna
    Wang, Xiao-Jing
    Edil, Barish H.
    Barnett, Carlton C.
    Schulick, Richard D.
    Chen, Lieping
    Zhu, Yuwen
    SCIENCE TRANSLATIONAL MEDICINE, 2021, 13 (604)
  • [24] The analysis of multiple omics and examination of pathological images revealed the prognostic and therapeutic significances of CD93 in lung squamous cell carcinoma
    Qu, Jialin
    Lin, Li
    Fu, Guangming
    Zheng, Mei
    Geng, Jiaxiao
    Sun, Xiaorong
    Xing, Ligang
    LIFE SCIENCES, 2024, 339
  • [25] Regulation of CD93 cell surface expression by protein kinase C isoenzymes
    Ikewaki, N
    Kulski, JK
    Inoko, H
    MICROBIOLOGY AND IMMUNOLOGY, 2006, 50 (02) : 93 - 103
  • [26] CD93 maintains endothelial barrier function by limiting the phosphorylation and turnover of VE-cadherin
    Lugano, Roberta
    Vemuri, Kalyani
    Barbera, Stefano
    Orlandini, Maurizio
    Dejana, Elisabetta
    Claesson-Welsh, Lena
    Dimberg, Anna
    FASEB JOURNAL, 2023, 37 (04)
  • [27] CD93 Signaling via Rho Proteins Drives Cytoskeletal Remodeling in Spreading Endothelial Cells
    Barbera, Stefano
    Raucci, Luisa
    Lugano, Roberta
    Tosi, Gian Marco
    Dimberg, Anna
    Santucci, Annalisa
    Galvagni, Federico
    Orlandini, Maurizio
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (22)
  • [28] CD93 blockade promotes effector T-cell infiltration and facilitates adoptive cell therapy in solid tumors
    Sun, Yi
    Yee, Elliott
    Fujiwara, Yuki
    Dickinson, Kaitlyn
    Guo, Yujie
    Sun, Zhiwei
    Hu, Junyi
    Davila, Eduardo
    Schulick, Richard D.
    Zhu, Yuwen
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2025, 13 (01)
  • [29] Diagnostic and Prognostic Role of CD93 in Cardiovascular Disease: A Systematic Review
    Piani, Federica
    Tossetta, Giovanni
    Cara-Fuentes, Gabriel
    Agnoletti, Davide
    Marzioni, Daniela
    Borghi, Claudio
    BIOMOLECULES, 2023, 13 (06)
  • [30] The Binding of CD93 to Multimerin-2 Promotes Choroidal Neovascularization
    Tosi, Gian Marco
    Neri, Giovanni
    Barbera, Stefano
    Mundo, Lucia
    Parolini, Barbara
    Lazzi, Stefano
    Lugano, Roberta
    Poletto, Evelina
    Leoncini, Lorenzo
    Pertile, Grazia
    Mongiat, Maurizio
    Dimberg, Anna
    Galvagni, Federico
    Orlandini, Maurizio
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (08)